Skip to main content

9 December 2022

Last updated: Sunday 4 December 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

Biotec Pharmacon ASA
Avacta Group Plc
Genmab A/S
Cancer Research UK
Diaccurate SAS
Achilles Therapeutics Ltd
Alzheimer's Drug Discovery Foundation
Themis Bioscience GmbH
F2G Ltd
AurorA Science

Interviewees and Contributers

Jean-Claude Muller
Mark Rothera
Roch Doliveux
Tim Farries
Marie Manley and Zina Chatzidimitriadou
Cecil Nick
Johan Strömquist
Tony Sedgwick
Emanuel Björne
Michael Nowak

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Stephen Burbidge to head research at Rewind Therapeutics

Sunday 4 December 2022

Richard Francis appointed CEO of Teva Pharmaceutical

Sunday 4 December 2022

Frank Mathias appointed CEO of Oxford Biomedica

Sunday 27 November 2022

Grünenthal appoints chief commercial officer

Sunday 27 November 2022

Richard Bungay joins Imophoron as CEO

Saturday 19 November 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form